BioMarin Pharmaceutical (NASDAQ:BMRN) executives used a fireside chat at TD Cowen’s 46th Annual Healthcare Conference to ...
As science becomes increasingly specialized and healthcare markets grow more complex, pharma commercial teams must focus on alignment and reliability, says Ed Park, vice president of strategy, Veeva ...
The MarketWatch News Department was not involved in the creation of this content. -- Mark Flather and Dr. Fred Brown join to expand adoption of Derisq(TM) and Operon(TM), delivering AI-powered risk ...
The MarketWatch News Department was not involved in the creation of this content. Company expands leadership team as customer base grows and platform drives measurable commercial impact BOSTON, Nov.
The healthcare industry struggles with siloed operations, limiting the potential of precision medicine and integrated care pathways. Successful integration examples, such as Roche and Abbott, ...
ABIONYX Pharma, (FR0012616852 - ABNX - PEA PME eligible), a next-generation biopharma company pioneering a new therapeutic era in sepsis and critical care through its proprietary apoA-I–based ...
BERLIN--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company specializing in the development of novel therapies for cancer and eye ...
RoslinCT, a global contract development and manufacturing organization (CDMO) specializing in advanced cell therapies, and BOOST Pharma, a clinical-stage biotechnology company developing ...
SAN DIEGO--(BUSINESS WIRE)--MEI Pharma, Inc. (NASDAQ: MEIP) (“MEI” or the “Company”) today announced that it will change its corporate name to Lite Strategy, Inc., reflecting the Company’s expansion ...
Shawn Patrick O’Brien stepped down as CEO and managing director, and Aaron Gray, currently Mayne Pharma’s chief financial ...
Mark Flather and Dr. Fred Brown join to expand adoption of Derisq™ and Operon™, delivering AI-powered risk prediction and portfolio optimization for biotech investors and pharmaceutical partners.